(Reuters) – Merck & Co said on Wednesday Chief Executive Officer Rob Davis would succeed Chairman Ken Frazier, taking on the additional role effective Dec. 1. Frazier, who has been …
Topic:
merck’s
-
-
By Deena Beasley – Rival antiviral pills from Pfizer Inc and Merck & Co that demonstrated efficacy in trials of adults with COVID-19 who are at high risk of serious …
-
By Deena Beasley – Merck & Co’s new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four available options for at-risk …
-
-Merck & Co said on Monday the U.S. Food and Drug Administration declined to approve its experimental drug for the treatment of chronic cough and sought additional information on the …